Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Regression Models and Life-Tables

1972 • 27,145 citations

Cancer statistics, 2000

2000 • 3,907 citations

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1997 • 1,621 citations

Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer

1999 • 1,224 citations

Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate Cancer

1997 • 1,140 citations

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1997 • 666 citations

Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer

1984 • 612 citations

Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial

1997 • 546 citations

Body Size and Prostate Cancer: A 20-Year Follow-up Study Among 135006 Swedish Construction Workers

1997 • 405 citations

Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters

1991 • 343 citations

Nutritional and Socioeconomic Factors in Relation to Prostate Cancer Mortality: a Cross-National Study

1998 • 336 citations

Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.

2001 • 320 citations

Pathogenesis of the decreased androgen levels in obese men

1994 • 285 citations

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

1993 • 259 citations

Race, Treatment, and Long-term Survival From Prostate Cancer in an Equal-Access Medical Care Delivery System

1995 • 255 citations

Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States).

1997 • 237 citations

Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate Cancer

1999 • 234 citations

Similarities of prostate and breast cancer: Evolution, diet, and estrogens

2001 • 222 citations

Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic Carcinoma

1991 • 180 citations

Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.

1996 • 126 citations

Pathogenesis of the decreased androgen levels in obese men.

1994 • 120 citations

Body Size and Prostate Cancer

2001 • 99 citations

Watchful waiting or watchful progression?

1998 • 98 citations

Watchful Waiting or Watchful Progression? Prostate Specific Antigen Doubling Times and Clinical Behavior in Patients With Early Untreated Prostate Carcinoma

1998 • 95 citations

Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036.

1994 • 90 citations

Osteoporosis due to androgen deprivation therapy in men with prostate cancer

2001 • 71 citations

Serum Markers as a Predictor of Response Duration and Patient Survival After Hormonal Therapy for Metastatic Carcinoma of the Prostate

1997 • 53 citations

STATISTICAL CONSIDERATIONS WHEN ASSESSING OUTCOMES FOLLOWING TREATMENT FOR PROSTATE CANCER

1999 • 44 citations

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era

1996 • 38 citations

Double-blind study of Anandron versus placebo in stage D2 prostate cancer patients receiving buserelin. Results on 49 cases from a multicentre study.

1987 • 33 citations